drugset / Trial / NCT02219191

Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

NCT02219191

Unknown 150 enrolled Chengdu PLA General Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the Effect of Puerarin tablets versus statins in treating metabolism syndrome in patients with chronic rheumatic diseases

Timeline

Start
2014-08
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 20 mg Oral
Subject Puerarin Small molecule 50 mg Oral

Indications